EQT Life Sciences Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, EQT Life Sciences has invested in 15 companies.

EQT Life Sciences’ most common sectors for investment arelife science (64%) and medical products (30%) . The Firm’s most common investment types include venture (83%) and growth capital (11%). In total, EQT Life Sciences has invested in 7 US states and 10 different countries.

In the last 3 years, EQT Life Sciences has exited 6 companies. The Firm’s most common exit type is trade sale (86%). EQT Life Sciences’ largest (disclosed) exit occurred in 2024 when it sold Amolyt Pharma SAS for $1.1B.

Join Mergr to view EQT Life Sciences’ full profile and discover more large growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity54
    • M&A Buy Activity47
    • M&A Sell Activity7
  • Total Sectors Invested 5
  • Total Countries Invested 10
  • M&A Buy/Sell Connections 14

EQT Life Sciences

EQT Life Sciences

Johannes Vermeerplein 9,
Amsterdam, 1071 DV
Netherlands
+31 (0) 20 664 55 00
www.lspvc.com
lspamsterdam@lspvc.com


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Growth Capital, Stake Purchase, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Western Europe

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (4.4/yr) # 25 7 12 2 - 1 47
Sell (1.2/yr) # 1 - 1 - 1 4 7
vol $2.1B $2.1B
  54

Most Recent M&A

Company Date Value Type
Endotronix, Inc. 2024-08-20 - Trade Sale
Lisle, Illinois · www.endotronix.com
Lumeon, Inc. 2024-08-08 - Trade Sale
Boston, Massachusetts · www.lumeon.com
Asceneuron SA 2024-07-16 - Growth Capital
Lausanne, Switzerland · www.asceneuron.com
Cardior Pharmaceuticals GmbH 2024-03-25 1.0B USD Trade Sale
Hannover, Germany · www.cardior.de
Amolyt Pharma SAS 2024-03-14 1.1B USD Trade Sale
Ecully, France · www.amolytpharma.com
Atlantic Therapeutics Group Ltd. 2023-09-06 - Trade Sale
Galway, Ireland · ie.myinnovo.com
Perfuze Ltd. 2022-02-09 - Venture
Galway, Ireland · www.perfuze.com
Nobi BV 2022-01-27 - Growth Capital
Antwerp, Belgium · www.nobi.life
AviadoBio Ltd. 2021-12-08 - Venture
London, United Kingdom · www.aviadobio.com
HotSpot Therapeutics, Inc. 2021-11-30 - Venture
Boston, Massachusetts · www.www.hotspotthera.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 26 (67%) - 30 (64%) -
Medical Products 11 (28%) - 14 (30%) -
Healthcare Services 1 (3%) - 1 (2%) -
Information Technology - - 1 (2%) -
Leisure 1 (3%) - 1 (2%) -
Total 39 - 47 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 8 (21%) - 11 (23%) -
  California 2 (5%) - 3 (6%) -
  Massachusetts 2 (5%) - 3 (6%) -
  Washington 1 (3%) - 1 (2%) -
  Rhode Island 1 (3%) - 1 (2%) -
  Pennsylvania 1 (3%) - 1 (2%) -
  North Carolina 1 (3%) - 1 (2%) -
  Illinois - - 1 (2%) -
Netherlands 8 (21%) - 10 (21%) -
Belgium 5 (13%) - 5 (11%) -
Ireland 4 (10%) - 5 (11%) -
France 3 (8%) - 4 (9%) -
Germany 3 (8%) - 4 (9%) -
Switzerland 3 (8%) - 3 (6%) -
United Kingdom 2 (5%) - 2 (4%) -
Denmark 2 (5%) - 2 (4%) -
Sweden 1 (3%) - 1 (2%) -
Total 39 - 47 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 32 (82%) - 39 (83%) -
Growth Capital 5 (13%) - 5 (11%) -
Stake Purchase 1 (3%) - 2 (4%) -
Buyout (LBO, MBO, MBI) 1 (3%) - 1 (2%) -
Total 39 - 47 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 4 (57%) 2.1B (100%)
Trade Sale 2 (29%) -
IPO 1 (14%) -
Total 7 $2.1B

Deal Values

sell # Total
> $1B 2 $2.1B
TOTAL $2.1B
Largest Amolyt Pharma SAS
$1.1B (2024-03-14)

M&A Connections

Deals
Exited to
Strategic(s)
86%
6 (86%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Large

PE Assets

2.0B USD

Established

1987

Specialist/Generalist

Specialist

Subsidiary of

EQT

FAQ

When was EQT Life Sciences founded?

EQT Life Sciences was founded in 1987.

What type of investor is EQT Life Sciences?

EQT Life Sciences is a growth capital firm.

Where is EQT Life Sciences headquartered?

EQT Life Sciences is headquartered in Amsterdam, Netherlands.

How much capital does EQT Life Sciences have under management?

EQT Life Sciences has 2.0B USD under management.

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal